TNF-α inhibitors are also widely used clinically, including infliximab, etanercept, adalimumab, golimumab and certolizumab (TNF-α inhibitors), which can treat RA by antagonizing TNF-α (Leone et al., 2023). Here, TNF is linked to rheumatoid arthritis.